Anupam Rasayan India Ltd. · NSE:ANURAS
Anupam Rasayan India — Q4 FY21 Earnings Presentation
37 slides from Anupam Rasayan India's earnings presentation, Jun 12, 2021
Slide 1: Stock exchange cover letter for investor presentation
ANUPAM RASAYAN INDIA LTD. Date: June 12, 2021 ARILSLDSTX20210612006 To, To, BSE Limited, Sr. General Manager Phiroze Jeejeebhoy Towers, National Stock Exchange of India Limited Dalal Street, 'Exchange Plaza', C-1, Block-G, Mumbai-400001,lndia Bandra Kurla Complex SCRIP CODE: 543275 Bandra (East), Mu
Slide 2: Investor Presentation Q4FY21 & FY21
ANUPAM RASAYAN INDIA ANUPAM RASAYAN INDIA LIMITED LIMITED INVESTOR PRESENTATION BSE: 543275 | NSE: ANURAS | ISIN: INE930P01018 Q4FY21 & FY21 ©2020 – Anupam Rasayan India Limited, All Rights Reserved. JUNE 2021
Slide 3: Tables of Contents
Tables of Contents - COMPANY 01 Slide 03 I FINANCIALS 02 Slide 08 I STRATEGIC PRIORITIES 03 Slide 16 I OUR BUSINESS 04 Slide 20 I TEAM 05 Slide 28 I INDUSTRY TRENDS 06 Slide 30
Slide 4: Company
COMPANY About Anupam Slide 04 Business Verticals Slide 05 Making a Mark Globally Slide 06 Key Strength Slide 07
Slide 5: About Anupam
COMPANY About Anupam - COMPANY AT A GLANCE - Established Custom Synthesis player Specialises in multi-step Catering to globally relevant Strong supply chain with backward with 37 years of track record synthesis undertaking complex chemical & agrochemical integrated facilities chemical reactions to p
Slide 6: Business Verticals
COMPANY Business Verticals - BUSINESS VERTICALS OVERVIEW HISTORICAL BUSINESS PERFORMANCE - - Revenue from Life Science (In ₹ Mn) c Life Science Related Other Specialty Specialty Chemicals Chemicals FY 21 7,429 92% FY 20 5,044 c 95% c Agrochemicals Specialty Pigments (including Crop Protection) FY 19
Slide 7: Making a Mark Globally
COMPANY Making a Mark Globally - MANUFACTURING CLIENTELE UNITS IN INDIA GLOBALLY (In Nos.) (In Nos.) 6* 64* REVENUE BY GEOGRAPHY - ■ EUROPE 43% ■ EUROPE 37% ■ EUROPE 36% ■ EUROPE 28% ■ INDIA 40% ■ INDIA 40% ■ INDIA 32% ■ INDIA 42% 2018 ■ SINGAPORE 12% 2019 ■ SINGAPORE 12% 2020 ■ SINGAPORE 17% 2021 ■
Slide 8: Key Strength: Customer Stickiness
COMPANY Key Strength: Customer Stickiness -• Long-standing relationships, clients onboarded FEW OF OUR TOP GLOBAL CLIENTS - after significant gestation period • Stringent customer audits, approvals & requirements adhered syngenta • SUMITOMO CHEMICAL • Dealing with top MNC’s around the globe supplyin
Slide 9: Financials
FINANCIALS Quarterly Financial Highlights Slide 09 « - Financial Summary Slide 10 Highlights & Ratio Analysis Slide 12
Slide 10: Quarterly Financial Highlights
FINANCIALS Quarterly Financial Highlights - Operating Revenue was EBITDA (Incl. Other Revenue) was PAT stood at ₹ 221 Mn., ₹ 2,717 Mn.; Y-o-Y growth of 73% ₹ 655 Mn.; Y-o-Y growth of 60% Y-o-Y growth of 113% PAT Margin grew by 179bps Repaid significant debt by stood at 8% for Q4FY21 utilizing the IP
Slide 11: Profit & Loss Summary
FINANCIALS Profit & Loss Summary - (All amounts are in ₹ Mn) Q4FY20 Q4FY21 FY20 FY21 INCOME Revenue from Operations 1,571 2,717 5,289 8,109 Other Income 82 25 109 264 Total Revenue 1,653 2,742 5,398 8,373 Total Revenue Growth (%) 66% 55% EXPENSES: Cost of Raw Materials Consumed 675 1,213 2,105 3,390
Slide 12: Balance Sheet Summary
FINANCIALS Balance Sheet Summary - (All amounts are in ₹ Mn) FY20 FY21 Shareholders’ Funds 5,935 15,734 Non-Current Liabilities 6,335 4,001 Long-Term Borrowings 5,814 3,435 Other Long-Term Borrowings 520 566 Current Liabilities 4,373 3,245 Short-Term Borrowings 2,371 433 Trade Payables 1,302 1,996 O
Slide 13: Highlights & Ratio Analysis (1/2)
FINANCIALS Highlights & Ratio Analysis (1/2) - REVENUE FROM OPERATIONS, EBITDA & EBITDA FIXED ASSETS & FIXED ASSET TURNOVER RATIO NET-DEBT, EQUITY & NET DEBT TO EQUITY - MARGINS ( In ₹ Mn and %) - (In ₹ Mn & Times) - (In ₹ Mn & Times) 9,000 14,000 0.76 18,000 27% 26% 0.70 8,000 16,000 1.31 1.33 12,0
Slide 14: Highlights & Ratio Analysis (2/2)
FINANCIALS Highlights & Ratio Analysis (2/2) - - CAPITAL EMPLOYED & ROCE (In ₹ Mn and %) - Profit After Tax (In ₹ Mn) - SHAREHOLDERS FUNDS & ROE (In ₹ Mn & Times) 25,000 800 18,000 10% 11% 11% 12% 700 ....., 16,000 20,000 9% 14,000 10% 600 10% • Return on Equity will improve - 15,000 500 - 12,000 si
Slide 15: IPO Fund Utilization & Impact Analysis
FINANCIALS IPO Fund Utilization & Impact Analysis - The net proceeds of the Issue was proposed to be utilized in the following manner: • Prepayment of certain indebtedness availed by the Company of ₹ 5,637 Mn • Net worth stands at over • Enhance our visibility and our brand image among our existing
Slide 16: Managing Director's Message
FINANCIALS Managing Director’s Message - Mr. Anand S Desai M A N A G I N G D I R E C TO R We built on the momentum that we had in FY 20 across all our markets and product segments in FY 21. This fiscal was a unique one in the history of the Company as we went public with strong support from our este
Slide 17: Strategic Priorities
STRATEGIC PRIORITIES Key Strategic Priorities Slide 17 EHS at Anupam Rasayan Slide 18 -%
Slide 18: Key Strategic Priorities
STRATEGIC PRIORITIES Key Strategic Priorities - CONTINUE TO FOCUS ON CSM DIVERSIFY PRODUCT PORTFOLIO BY DEVELOPING INNOVATIVE AND EXPAND CHEMISTRY PROCESSES AND VALUE EXPERTISE - ENGINEERING EXPAND BUSINESS BY CONTINUE TO FOCUS ON COST CAPITALIZING ON INDUSTRY EFFICIENCY AND IMPROVING OPPORTUNITIES
Slide 19: EHS at Anupam Rasayan
STRATEGIC PRIORITIES EHS at Anupam Rasayan - WASTE MANAGEMENT ENVIRONMENT MANAGEMENT SAFETY - - - COMMITED TO MAKE POSITIVE IMPACT WE BELIEVE PROTECTING THE WELL BEING COMMITTED TO CONDUCTING ALL OUR ON THE ENVIRONMENT OF OUR EMPLOYEE AND ENVIRONMENT IS OPERATION IN SAFE AND RELIABLE OUR RESPONSIBIL
Slide 20: EHS at Anupam Rasayan (cont.)
STRATEGIC PRIORITIES EHS at Anupam Rasayan(cont.) - pr I o I +@4 SUSTAINABILITY CSR ACTIVITIES AWARDS & RECOGNITION - • Installation of Solar Power plant to reduce - • Sickle Cell Disease comprehensive care - dependency program • Use of Natural gas-based steam • To reduce Neonatal Mortality Rate (NM
Slide 21: Our Business
OUR BUSINESS Evolution of Anupam Slide 21 Strong Technical Capabilities Slide 22 Anupam’s Value Chain Slide 24 Infrastructure Slide 25
Slide 22: Evolution of Anupam
OUR BUSINESS Evolution of Anupam dd -r d e8» .ii 2 ... s d 0 0 $78 Company was formed as a Started supplying specialty Awarded ‘Green Innovation Commercialized Unit – 5 in • Started partnership firm as “Anupam chemicals to Syngenta Award’ by Corning Reactor Jhagadia GIDC and Unit – 6 in working with
Slide 23: Strong Technical Capabilities
OUR BUSINESS Strong Technical Capabilities - COMPETENCE IN KEY CHEMISTRIES DSIR recognized R&D center R&D headed by Dr. Nileshkumar Naik, with team of 55 - professionals Etherification Chlorination Diazotization & hydrolysis R&D team oversees transfer of Received the ‘Corning Green technology from l
Slide 24: Strong Technical Capabilities (Contd.)
OUR BUSINESS Strong Technical Capabilities (Contd.) - PROCESS TECHNOLOGIES DEPLOYED - Flow Chemistry Photo Chemistry Significant advantages of flow chemistry technology over traditional Increasingly becoming an important tool in the search of new active batch process : compounds for specialty chemic
Slide 25: Anupam's Value Chain
OUR BUSINESS Anupam’s Value Chain - 3 MONTHS 3 MONTHS Response Signing Customer with NDA / Process R&D Testing Sample inquiry Feasibility Confidential Evaluation and Trials Costing study agreement l Plant Commercial Raw Material Modification/ Customer Sample Pilot-scale Customer Production Procureme
Slide 26: World-class Infrastructure
OUR BUSINESS World-class Infrastructure - • Manufacturing operations were commenced in 1984 HIGHLIGHTS • Highly automated multi-purpose facilities • Equipped with glass-lined, titanium cladded and stainless-steel reactors - 69 enabling manufacture of diverse range of products & • Strategically locat
Slide 27: Production Facilities (1/2)
• OUR BUSINESS Production Facilities (1/2) 'e ® - INFRASTRUCTURE – UNIT IV PRODUCTION SITE (JHAGADIA) - INFRASTRUCTURE – UNIT V PRODUCTION SITE (JHAGADIA) - ANUPAM RASAYAN INDIA LIMITED | 26
Slide 28: Production Facilities (2/2)
OUR BUSINESS Production Facilities (2/2) -- INFRASTRUCTURE – UNIT III (SACHIN) NEW R&D CENTRE AND PILOT FACILITIES - g« N - =ii+ _ a. - . ., . � :'rlh1 �· •�--:-"iii • .-. � ----=- milt ' ANUPAM RASAYAN INDIA LIMITED | 27
Slide 29: Team
TEAM Board of Directors Slide 29 «
Slide 30: Board of Directors
TEAM Board of Directors - 3 DR. KIRAN C PATEL CHAIRMAN & MR. ANAND S DESAI MANAGING DIRECTOR A MS. MONA A DESAI VICE-CHAIRMAN & ls MR. MILAN THAKKAR NON-EXECUTIVE DIRECTOR - NON-EXECUTIVE DIRECTOR • Associated with the company for past 5 years and intends to stay committed with company for long term
Slide 31: Industry Trends
INDUSTRY TRENDS Indian Chemical Industry Slide 31 CRAMS Industry Overview Slide 32 Specialty Chemicals – Industry Overview Slide 33 Agrochemicals & API – Industry Overview Slide 34
Slide 32: Indian Chemical Industry at a Glance
INDUSTRY TRENDS Indian Chemical Industry at a Glance - USD 178 Bn 6th 80,000+ (FY20) Largest Chemical Products Producer of the world USD 130/month 100% FDI under Fast Growing verticals: Labor cost automatic rule Petrochemical, (one of Lowest in (except for Hazardous Specialty Chemical world) Chemica
Slide 33: CRAMS Industry Overview
INDUSTRY TRENDS CRAMS Industry Overview - GLOBAL CRAMS INDUSTRY OVERVIEW INDIAN CRAMS INDUSTRY OVERVIEW - - - GLOBAL MARKET SIZE (In $ Bn) ■ NORTH AMERICA 37% - INDIAN MARKET SIZE (In $ Bn) ■ GENERIC MOLECULES 75% ■ EUROPE 26% 2019 ■ PATENTED MOLECULES 25% 2019 ■ CHINA 15% ■ APAC 12% FY24F 322 INDIA
Slide 34: Specialty Chemicals – Industry Overview
INDUSTRY TRENDS Specialty Chemicals – Industry Overview - GLOBAL SPECIALTY CHEMICALS INDUSTRY OVERVIEW INDIAN SPECIALTY CHEMICALS INDUSTRY OVERVIEW - - - GLOBAL MARKET SIZE (In $ Bn) ■ APAC 44% - INDIAN MARKET SIZE (In $ Bn) ■ EUROPE 23% 2019 ■ NORTH AMERICA 21% ■ REST WORLD OF 12% FY24F 947 FY24F 3
Slide 35: Agrochemicals & API – Industry Overview
INDUSTRY TRENDS Agrochemicals & API – Industry Overview - AGROCHEMICALS API - - - GLOBAL MARKET SIZE (In $ Bn) - INDIAN MARKET SIZE (In $ Bn) - GLOBAL MARKET SIZE (In $ Bn) - INDIAN MARKET SIZE (In $ Bn*) FY24F 86 FY24F 6 FY24F 260 FY24F 15 FY19 63 FY19 5 FY19 193 FY19 10 FY14 49 FY14 4 FY14 151 FY1
Slide 36: Safe Harbor
Safe Harbor Safe Harbor - Certain statements in this presentation concerning our future growth prospects are forward looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company'
Slide 37: Thank You
'« • ® ANUPAM RASAYAN INDIA LIMITED THANK YOU CONTACT US: MR. AFZAL MALKANI (CFO) Anupam Rasayan India Ltd. Tel: +91 261 2398991 investors@anupamrasayan.com MR. NIKHIL MORYE Christensen Investor Relations Tel: +91 22 4215 0210 nmorye@christensenir.com CORPORATE OFFICE Anupam Rasayan India Ltd. India